Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Rapid Micro Biosystems (Nasdaq: RPID), a life sciences technology company specializing in automation solutions for healthcare product manufacturing, has announced its participation in two upcoming investor conferences.

The company will deliver a presentation at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 11:10 a.m. ET in Boston, Massachusetts. Additionally, RPID will participate in a Q&A session at the KeyBanc Capital Markets Healthcare Forum, a virtual event scheduled for March 19, 2025, at 11:15 a.m. ET.

Both events will be accessible via live webcasts on the company's investor relations website at investors.rapidmicrobio.com, with recordings available for replay after the events.

LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences.

• TD Cowen 45^th Annual Health Care Conference
  Company presentation on Tuesday, March 4, 2025, at 11:10 a.m. ET in Boston, Massachusetts.

• KeyBanc Capital Markets Healthcare Forum (Virtual)
  Question-and-answer session with the host analyst on Wednesday, March 19, 2025, at 11:15 a.m. ET.

Live webcasts for both events will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.

FAQ

When is Rapid Micro Biosystems (RPID) presenting at the TD Cowen Healthcare Conference 2025?

RPID will present at the TD Cowen Healthcare Conference on Tuesday, March 4, 2025, at 11:10 a.m. ET in Boston, Massachusetts.

How can investors access RPID's upcoming March 2025 conference presentations?

Investors can access live webcasts of both presentations through RPID's investor relations website at investors.rapidmicrobio.com.

What is the schedule for RPID's KeyBanc Capital Markets Healthcare Forum participation?

RPID will participate in a Q&A session at the virtual KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025, at 11:15 a.m. ET.

Will recordings of RPID's March 2025 investor conferences be available?

Yes, webcasts of both events will be archived and available for replay after the events on RPID's investor relations website.